Acquired
ZappRx Stock
Prescription & Prior Authorization Platform
Sign up today and learn more about ZappRx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About ZappRx Stock
ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are managed. We provide a secure, collaborative online platform that allows patients, physicians, and pharmacists to work together to improve patients’ access to treatment and deliver medicine faster.
Investors
Funding History
September 2013 | $1.0M |
---|---|
January 2014 | $1.0M |
April 2015 | $14.0M |
April 2017 | $25.0M |
Management
Founder & CEO
Zoe Barry
Chief Operating Officer
Sandy DiCesare
Press
Business Wire (press release) - Nov, 28 2017
ZappRx Bolsters Company Growth with Strategic Executive Hires, and Advances Mission to Streamline Specialty ...Business Wire (press release) - Nov, 21 2017
Matter Communications Named PR Agency of Record (AOR) for ZappRxLung Disease News - Jul, 25 2017
ZappRx Implements Specialty Medication Prescribing Platform at 2 Pulmonary Medical CentersPR Newswire (press release) - Jul, 20 2017
ZappRx Launches Specialty Drug Prescribing Platform at Arizona Pulmonary Specialists and Harbor-UCLA Medical ...TechCrunch - Apr, 20 2017
ZappRX gets $25 million from Qiming US to expand into the US drug prescription market